Alx Oncology Holdings Inc (ALXO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alx Oncology Holdings Inc  (NASDAQ: ALXO)


Alx Oncology Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alx Oncology Holdings Inc's ROI in the second quarter of 2026?
Alx Oncology Holdings Inc recorded a cumulative net loss of $-81 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -80.34%.

Within the Healthcare sector 572 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3872 to 4079.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -12.69 % -42.22 % -58.06 % -49.35 % -38.34 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 155 158 34 55 76
Return On Investment (TTM) -80.34 % -109.67 % -151.71 % -119.05 % -101.09 %
ALXO's Overall Ranking # 4079 # 3872 # 2779 # 3590 # 3233
Seq. Investment Change TTM 24.26 % 20.88 % -26.12 % -21.33 % -17.77 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -81 -89 -102 -108 -117

ALXO Company Profile >> Back to ALXO Roi Comparisons >> See Annual ALXO Return On Investment



Return On Investment ALXO's Ranking
Within: No.
Industry # 256
Sector # 573
Overall # 4079

Return On Investment Statistics
High Average Low
-2.51 %
-60.37 %
-151.71 %
(Dec 31 2020)   (Dec 31 2025)







Financial Statements
Alx Oncology Holdings Inc's II. Quarter Investments $ 155 Millions ALXO's Balance sheet
Alx Oncology Holdings Inc's II. Quarter Income $ -18 Millions Quarterly ALXO's Income Statement
ALXO's Income by Division See ALXO's Income by Division


ALXO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 34 129 207 278 365
Y / Y Investment Growth -73.32 % -37.41 % -25.74 % -23.77 % -15.11 %
Net Income in Millions -102 -135 -161 -123 -83
Y / Y Net Income Growth - - - - -
Annual Return On Investment -294.83 % -104.31 % -77.85 % -44.39 % -22.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALXO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALXO's Competitors
Subscribers only: Roi for Alx Oncology Holdings Inc's Suppliers
Subscribers only: Return On Investment for ALXO's Customers

Other Ratios
ALXO's Roa ALXO's Inventory Turnover Ratio ALXO's Growth Rates ALXO's Dividend Statistics
ALXO's Profitability Ratios ALXO's Asset Turnover Ratio ALXO's Dividend Growth
ALXO's Roe ALXO's Valuation Ratios ALXO's Financial Strength Ratios ALXO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:38:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.